Betulinic Acid

DB12480ApprovedWithdrawnSmall molecule

Betulinic Acid has been used in trials studying the treatment of Dysplastic Nevus Syndrome.

Chemical structure of Betulinic Acid
Formula / weight
C30H48O3 · 456.711 g/mol (avg)
Also known as
beta-betulinic acid
Code names
ALS-357 · NSC-113090

Resolves to

Compound
UNII4G6A18707NCAS472-15-1ChEMBLCHEMBL269277ChEBI3087PubChem64971KEGGC08619
Structure
InChIKeyQGJZLNKBHJESQX-FZFNOLFKSA-NSMILES[H]OC(=O)[C@]12CC[C@@]([H])(C(C)=C)[C@]1([H])[C@@]1([H])CC[C@]3([H])[C@@]4(C)CC[C@]([H])(O[H])C(C)(C)[C@]4([H])CC[C@@]3(C)[C@]1(C)CC2
Targets
P04293DNA polymerase catalytic subunit

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
145Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Marketed productsAcross 2 countries and 2 labellers
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Betulinic Acid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In